Systemic chemotherapy with doxorubicin, cisplatin and capecitabine for metastatic hepatocellular carcinoma

Systemic chemotherapy with doxorubicin, cisplatin and capecitabine for metastatic hepatocellular carcinoma

<p>Abstract</p> <p>Background</p> <p>Although numerous chemotherapeutic agents have been tested, the role of systemic chemotherapy for hepatocellular carcinoma (HCC) has not been clarified. New therapeutic strategies are thus needed to improve outcomes, and we designed...

Full description

Bibliographic Details
Main Authors:	Bang Soo-Mee, Lee Jeong, Park Yeon, Kim Ju, Kim Sun, Kwon Oh, Kwon So, Han Sang, Lee Yuna, Park Se, Cho Eun, Shin Dong, Lee Jae
Format:	Article
Language:	English
Published:	BMC 2006-01-01
Series:	BMC Cancer
Online Access:	http://www.biomedcentral.com/1471-2407/6/3

Similar Items

Capecitabine and cisplatin (XP) combination systemic chemotherapy in heavily pre-treated HER2 negative metastatic breast cancer.
by: Jieun Lee, et al.
Published: (2017-01-01)

Metronomic capecitabine versus doxorubicin in advanced hepatocellular carcinoma
by: Gehan Abd Elatti Khedr, et al.
Published: (2016-06-01)

Docetaxel plus cisplatin is effective for patients with metastatic breast cancer resistant to previous anthracycline treatment: a phase II clinical trial
by: Lee Jae, et al.
Published: (2005-02-01)

Intra-Arterial Chemotherapy with Doxorubicin and Cisplatin Is Effective for Advanced Hepatocellular Cell Carcinoma
by: Ming-Chun Ma, et al.
Published: (2014-01-01)

Randomized phase II study of capecitabine plus cisplatin with or without sorafenib in patients with metastatic gastric cancer (STARGATE)
by: Min‐Hee Ryu, et al.
Published: (2023-04-01)

Retrospective analyses of cisplatin-based doublet combination chemotherapy in patients with advanced gastric cancer
by: Kim Hyeong, et al.
Published: (2010-10-01)

Chemotherapy for Metastatic Gastric Cancer
by: Sung Eun Kim, et al.
Published: (2025-01-01)

Acute Aortic Thrombosis Following Capecitabine Chemotherapy in a Patient with Colon Cancer
by: Min Kyung Lee, et al.
Published: (2018-09-01)

Lymphocyte-monocyte ratio at day 14 of first cisplatin-doxorubicin chemotherapy is associated with treatment outcome of pediatric patients with localized osteosarcoma
by: Jun Ah Lee, et al.
Published: (2019-02-01)

Prolonged Endurance Exercise Adaptations Counteract Doxorubicin Chemotherapy-Induced Myotoxicity in Mice
by: Insu Kwon, et al.
Published: (2022-04-01)

Capecitabine Maintenance Chemotherapy in the Treatment of Metastatic Colorectal Cancer: A Meta-Analysis
by: Bradley Ashley Gue Ong, et al.
Published: (2022-04-01)

Identification of a biomarker to predict doxorubicin/cisplatin chemotherapy efficacy in osteosarcoma patients using primary, recurrent and metastatic specimens
by: Qiong Ma, et al.
Published: (2024-11-01)

The results of primary chemotherapy of TS-1/cisplatin regimen in unresectable or metastatic gastric cancer patients
by: Jung Hyun Song, et al.
Published: (2014-06-01)

Olaratumab and doxorubicin for the treatment of metastatic soft tissue sarcoma: a retrospective case series
by: Joon Young Hur, et al.
Published: (2019-06-01)

Neoadjuvant chemotherapy with gemcitabine and cisplatin followed by selective bladder preservation chemoradiotherapy in muscle-invasive urothelial carcinoma of bladder
by: Hyun Hwan Sung, et al.
Published: (2022-03-01)

gene amplification in patients with metastatic cancer
by: Su Jin Lee, et al.
Published: (2017-09-01)

Real-world efficacy and safety of capecitabine with oxaliplatin in patients with advanced adenocarcinoma of the ampulla of Vater
by: Seunghwan Lee, et al.
Published: (2024-05-01)

Occupational Exposure during Intraperitoneal Pressurized Aerosol Chemotherapy Using Doxorubicin in a Pig Model
by: Wongeon Jung, et al.
Published: (2023-06-01)

Neoadjuvant Bevacizumab Plus Docetaxel/Cisplatin/Capecitabine Chemotherapy in Locally Advanced Gastric Cancer Patients: A Pilot Study
by: Deguo Yu, et al.
Published: (2022-05-01)

Switching cisplatin to carboplatin in chemotherapy for metastatic penile cancer in a patient intolerant to cisplatin
by: Keita Sekine, et al.
Published: (2024-11-01)

Capecitabine and temozolomide for metastatic intermediate to high-grade pancreatic neuroendocrine neoplasm: a single center experience
by: Sathathone Douangprachanh, et al.
Published: (2022-11-01)

Maintenance chemotherapy after 6 cycles of platinum-doublet regimen in anthracycline-and taxane-pretreated metastatic breast cancer
by: Eun Kyo Joung, et al.
Published: (2021-01-01)

Efficacy of capecitabine and oxaliplatin versus S-1 as adjuvant chemotherapy in gastric cancer after D2 lymph node dissection according to lymph node ratio and N stage
by: Kabsoo Shin, et al.
Published: (2019-12-01)

Cisplatin combined with capecitabine-induced chemotherapy for local nasopharyngeal carcinoma can improve the quality of life and reduce toxic and side effects
by: Ying Gao, et al.
Published: (2021-09-01)

Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy
by: Kim Dong-Wan, et al.
Published: (2007-04-01)

Oral Capecitabine Achieves Response in Metastatic Eccrine Carcinoma
by: Kristian Larson, et al.
Published: (2018-01-01)

Assessing the Percent of Necrosis after Neoadjuvant Chemotherapy with 24hr Infusional Cisplatin/3 Days Doxorubicin Intermittent with IfosfamideDoxorubicin for Osteosarcoma
by: Mozhgan Aalam Samimi, et al.
Published: (2014-03-01)

Gemcitabine–cisplatin versus MVAC chemotherapy for urothelial carcinoma: a nationwide cohort study
by: Yong Seong Lee, et al.
Published: (2023-03-01)

Impact of prior chemotherapy with two different fluoropyrimidines on the efficacy of capecitabine plus irinotecan or FOLFIRI with or without bevacizumab in metastatic colorectal cancer: a post hoc analysis of the AXEPT study
by: Satoru Iwasa, et al.
Published: (2023-04-01)

Treatment patterns and outcomes in patients with metastatic gastric cancer receiving third-line chemotherapy: A population-based outcomes study.
by: In Sil Choi, et al.
Published: (2018-01-01)

Pressurized intraperitoneal aerosol chemotherapy with cisplatin and doxorubicin or oxaliplatin for peritoneal metastasis from pancreatic adenocarcinoma and cholangiocarcinoma
by: Andrea Di Giorgio, et al.
Published: (2020-07-01)

CAPECITABINE IN THE TREATMENT OF BRAIN METASTATIC LESION IN PATIENTS WITH BREAST CANCER
by: E. A. Moskvina, et al.
Published: (2015-04-01)

Real-world outcomes of adjuvant gemcitabine gemcitabine plus capecitabine for resected pancreatic ductal adenocarcinoma
by: Sora Kang, et al.
Published: (2022-05-01)

Endostar Combined with Gemcitabine and Cisplatin Chemotherapy for Patients with Metastatic Nasopharyngeal Carcinoma: an Update
by: Ting Jin, et al.
Published: (2018-04-01)

Cisplatin and vinorelbine in the treatment of locally advanced and metastatic non-small cell lung cancer
by: Wong, Catherine Mee Ming, et al.
Published: (2001)

Efficacy of Capecitabine Plus Oxaliplatin Combination Chemotherapy for Advanced Pancreatic Cancer after Failure of First-Line Gemcitabine-Based Therapy
by: Kwang Hyun Chung, et al.
Published: (2017-03-01)

Economic evaluation of third-line neratinib plus capecitabine versus lapatinib plus capecitabine with HER2+ metastatic breast cancer
by: Lanqi Ren, et al.
Published: (2023-08-01)

Milnacipran Has an Antihyperalgesic Effect on Cisplatin-Induced Neuropathy
by: Sun Jin Cho, et al.
Published: (2023-08-01)

Different metastatic pattern according to the KRAS mutational status and site-specific discordance of KRAS status in patients with colorectal cancer
by: Kim Mi-Jung, et al.
Published: (2012-08-01)

Exploring the efficacy of fluorouracil and platinum based chemotherapy in advanced hepatocellular carcinoma to bridge the treatment gap in resource limited settings
by: Se Jun Park, et al.
Published: (2025-01-01)